onr:"swepub:oai:prod.swepub.kib.ki.se:141593502"
Search: onr:"swepub:oai:prod.swepub.kib.ki.se:141593502" > Xentuzumab (BI 8368...
- 1 of 1
- Previous record
- Next record
- To hitlist
Xentuzumab (BI 836845), an insulin-like growth factor (IGF)-neutralizing antibody (Ab), combined with exemestane and everolimus in hormone receptor-positive (HR plus ) locally advanced/metastatic breast cancer (LA/mBC): Randomized phase 2 results
- Crown, J (author)
- Sablin, MP (author)
- Cortes, J (author)
- show more...
- Bergh, J (author)
- Im, SA (author)
- Lu, YS (author)
- Martinez, N (author)
- Neven, P (author)
- Lee, KS (author)
- Morales, S (author)
- Perez-Fidalgo, JA (author)
- Adamson, D (author)
- Goncalves, A (author)
- Prat, A (author)
- Jerusalem, G (author)
- Schlieker, L (author)
- Espadero, RM (author)
- Bogenrieder, T (author)
- Huang, DCL (author)
- Schmid, P (author)
- show less...
- 2019
- 2019
- English.
- In: CANCER RESEARCH. - 0008-5472. ; 79:4
- Conference paper (other academic/artistic)
Subject headings
Close
Publication and Content Type
- vet (subject category)
- kon (subject category)
Find in a library
- CANCER RESEARCH (Search for host publication in LIBRIS)
To the university's database
- 1 of 1
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Crown, J
- Sablin, MP
- Cortes, J
- Bergh, J
- Im, SA
- Lu, YS
- show more...
- Martinez, N
- Neven, P
- Lee, KS
- Morales, S
- Perez-Fidalgo, J ...
- Adamson, D
- Goncalves, A
- Prat, A
- Jerusalem, G
- Schlieker, L
- Espadero, RM
- Bogenrieder, T
- Huang, DCL
- Schmid, P
- show less...
- Articles in the publication
- CANCER RESEARCH
- By the university
- Karolinska Institutet
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
